Therapeutic Administration Success Rates. حسب Alani Mohanad Khalid Ahmed (22693496)

CTL response following combination therapy with NDV. حسب Hedieh Zargaran (21410233)

الموضوعات:

Reasons for residual limb pain and corresponding therapeutic options, adapted from Dwornik et al. [6]. حسب Martin C. Berli (9427264)

Therapeutic effect of TAS5315 on the decrease in bone strength in a mouse CIA model. حسب Daichi Akasaka (14670684)

Determination of the splenic IFN- حسب Hedieh Zargaran (21410233)

الموضوعات:

LDH cytotoxicity assay results. حسب Hedieh Zargaran (21410233)

الموضوعات:

Lymphocyte proliferation assay following combination therapy with NDV. حسب Hedieh Zargaran (21410233)

الموضوعات:

Tumor volume measurements. حسب Hedieh Zargaran (21410233)

الموضوعات:

IFN-γ cytokine measurements. حسب Hedieh Zargaran (21410233)

الموضوعات:

IL-10 levels in tumor lysates post-treatment. حسب Hedieh Zargaran (21410233)

الموضوعات:

Tumor volume measurements. حسب Hedieh Zargaran (21410233)

الموضوعات:

MTT assay results. حسب Hedieh Zargaran (21410233)

الموضوعات:

IL-10 cytokine measurements. حسب Hedieh Zargaran (21410233)

الموضوعات:

IL-4 cytokine measurements. حسب Hedieh Zargaran (21410233)

الموضوعات:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. حسب Richard Junior Zapata Dongo (17912565)

Clinical factors affecting renal response to dulaglutide. حسب Sungmin Kim (628527)

الموضوعات:

The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes حسب Rebecca E. Moore (9518839)

الموضوعات:

The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes حسب Rebecca E. Moore (9518839)

الموضوعات:

The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes حسب Rebecca E. Moore (9518839)

الموضوعات:

CDK4/6 inhibition presents as a therapeutic option for pediatric and adult germ cell tumors and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms حسب Margaretha Skowron (3449309)

"…</p><p><b>Conclusion:</b> Our study highlights PaRi as therapeutic options for cisplatin-resistant and -sensitive pediatric and adult GCTs. …"